HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip L Lorenzi Selected Research

Apoptosis Regulatory Proteins

1/2022SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip L Lorenzi Research Topics

Disease

47Neoplasms (Cancer)
04/2024 - 11/2006
7Leukemia
01/2023 - 11/2006
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023 - 11/2006
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 08/2012
5Ovarian Neoplasms (Ovarian Cancer)
11/2023 - 11/2006
5Breast Neoplasms (Breast Cancer)
01/2022 - 09/2007
4Hepatocellular Carcinoma (Hepatoma)
01/2023 - 01/2021
4Carcinogenesis
09/2022 - 04/2017
3Fibrosis (Cirrhosis)
01/2022 - 01/2021
3Brain Neoplasms (Brain Tumor)
01/2021 - 01/2018
2Hypoxia (Hypoxemia)
11/2023 - 01/2018
2Fatty Liver
07/2023 - 01/2022
2Pneumonia (Pneumonitis)
01/2023 - 01/2023
2Adenocarcinoma
01/2023 - 10/2020
2Adenocarcinoma of Lung
09/2022 - 01/2022
2Melanoma (Melanoma, Malignant)
02/2022 - 01/2021
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 02/2016
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 01/2019
2Glioblastoma (Glioblastoma Multiforme)
11/2021 - 01/2021
2Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 02/2016
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2019 - 02/2016
2Genomic Instability
12/2009 - 09/2007
2Chromosome Aberrations (Chromosome Abnormalities)
09/2007 - 05/2007
1Parasitemia
01/2024
1Malaria
01/2024
1Cholangiocarcinoma
12/2023
1Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2023
1Skin Neoplasms (Skin Cancer)
11/2023
1Moyamoya Disease (Moya-Moya Disease)
10/2023
1Stroke (Strokes)
10/2023
1Inborn Errors Metabolism (Inborn Errors of Metabolism)
07/2023
1Body Weight (Weight, Body)
07/2023
1Hypoglycemia (Reactive Hypoglycemia)
07/2023
1Lipodystrophy
07/2023
1Lymphoma (Lymphomas)
01/2023

Drug/Important Bio-Agent (IBA)

12Asparaginase (Elspar)FDA Link
01/2023 - 11/2006
9Proteins (Proteins, Gene)FDA Link
01/2023 - 05/2007
8AsparagineIBA
11/2023 - 11/2006
7Glucose (Dextrose)FDA LinkGeneric
07/2023 - 01/2018
7Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA
01/2023 - 11/2006
7Glutamine (L-Glutamine)FDA Link
01/2023 - 06/2014
6EnzymesIBA
01/2022 - 11/2006
6Biomarkers (Surrogate Marker)IBA
10/2021 - 11/2006
5DNA (Deoxyribonucleic Acid)IBA
01/2023 - 11/2006
4LipidsIBA
04/2024 - 10/2021
4Fatty Acids (Saturated Fatty Acids)IBA
02/2022 - 01/2021
4GlutaminaseIBA
01/2022 - 06/2014
3Serine (L-Serine)FDA Link
12/2023 - 10/2018
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2018
3Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 01/2022
3IACS-010759IBA
02/2022 - 01/2019
3NADP (NADPH)IBA
01/2022 - 01/2018
3Messenger RNA (mRNA)IBA
01/2018 - 05/2007
2IonsIBA
01/2024 - 11/2023
2snake venom protein C activatorIBA
12/2023 - 01/2019
2Glycine (Aminoacetic Acid)FDA LinkGeneric
12/2023 - 10/2018
2Lactic Acid (Lactate)FDA LinkGeneric
11/2023 - 01/2020
2Oxygen (Dioxygen)IBA
11/2023 - 01/2020
2NucleotidesIBA
11/2023 - 01/2018
2Arginine (L-Arginine)FDA Link
10/2023 - 01/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2023 - 12/2014
2Pathogen-Associated Molecular Pattern MoleculesIBA
01/2023 - 01/2023
2Transcription Factors (Transcription Factor)IBA
01/2023 - 09/2021
2Glutamic Acid (Glutamate)FDA Link
01/2023 - 06/2014
2Cysteine (L-Cysteine)FDA Link
01/2023 - 01/2019
2Phosphotransferases (Kinase)IBA
01/2022 - 12/2009
2Amino AcidsFDA Link
10/2021 - 01/2019
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2018
2AntigensIBA
01/2021 - 10/2020
2Adenosine Triphosphate (ATP)IBA
11/2019 - 01/2018
2ibrutinibIBA
01/2019 - 02/2016
2Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 09/2007
2MicroRNAs (MicroRNA)IBA
10/2018 - 05/2007
2Small Interfering RNA (siRNA)IBA
07/2014 - 09/2007
1GoldIBA
01/2024
1Antimitotic AgentsIBA
01/2024
1InterferonsIBA
01/2024
1itaconic acidIBA
01/2024
1CarbonIBA
12/2023
1Drug CombinationsIBA
12/2023
1Tyrosine (L-Tyrosine)FDA Link
11/2023
1Aspartic Acid (Aspartate)FDA Link
11/2023
1Phenylalanine (L-Phenylalanine)FDA Link
11/2023
1Urea (Carbamide)FDA LinkGeneric
11/2023
1pyrimidineIBA
11/2023
1Proline (L-Proline)FDA Link
11/2023
1VitaminsIBA
07/2023
1FlavoproteinsIBA
07/2023
1Flavin-Adenine Dinucleotide (FAD)IBA
07/2023
1AntioxidantsIBA
01/2023
1GemcitabineFDA Link
01/2023
1Vincristine (Oncovin)FDA LinkGeneric
01/2023
1Oncogene Proteins (Oncogene Protein)IBA
01/2023
1Vitamin DFDA LinkGeneric
01/2023
1Calcitriol Receptors (Calcitriol Receptor)IBA
01/2023
1Phospholipid EthersIBA
01/2023

Therapy/Procedure

17Therapeutics
01/2024 - 01/2011
8Drug Therapy (Chemotherapy)
11/2023 - 02/2016
2Radiotherapy
01/2024 - 01/2019
2Neoadjuvant Therapy
11/2023 - 01/2023